Volume 19, Number 9—September 2013
Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA
We tested blood samples from domestic and captive farmed animals in Minnesota, USA, to determine exposure to severe fever with thrombocytopenia syndrome virus and Heartland-like virus. We found antibodies against virus nucleoproteins in 10%–18% of samples from cattle, sheep, goats, deer, and elk in 24 Minnesota counties.
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease in China, caused by a novel bunyavirus in the genus Phlebovirus (1). As many as 10,000 SFTS case-patients have been reported since disease emergence in 2009, with fatality rates ranging from 2% to 15% (1,2), mainly in the eastern provinces of China. SFTS bunyavirus (STFSV) appears to be transmitted by ticks, an unusual difference from other pathogenic phleboviruses, which are transmitted primarily by mosquitoes (3). Recently, a new phlebovirus, named the Heartland virus (HLV), was isolated in Missouri from patients with a history of tick bites and signs and symptoms similar to those of SFTS, including high fever and low blood leukocyte and platelet counts (4). Phylogenetic analysis showed that HLV is closely related to SFTSV, which suggests that this new phlebovirus could be a serious threat to public health in the United States.
Many bunyaviruses can infect animals (3). Little is known about the animal host species that carry HLV or HLV-like bunyaviruses in the United States. Serologic surveys in China found that farm animals, including cattle, goats, and sheep, were infected with SFTSV in disease-endemic areas. In these studies, viral RNA was identified in animal serum specimens, and these isolates shared high sequence homology with isolates from humans (5). Strikingly, up to 47% of farm animals in Jiangsu Province, China, had SFTSVs (4), indicating that active virus transmission is occurring in the rapidly expanding disease-endemic area. It is critical to identify animal hosts that may be susceptible to, and infected with, HLV or an SFTSV-like virus, and may serve as amplifying hosts that facilitate virus transmission in the United States. To identify animal hosts that may play an essential role in transmission of SFTSV- or HLV-like viruses in the United States, we conducted serologic testing of samples collected from farm animals in Minnesota, USA. Our findings raise the specter of widespread distribution of a novel pathogen among livestock and wildlife that has the potential to be transmitted to humans.
Blood samples, obtained from several domestic and captive farmed animals of various species, were analyzed at the Minnesota Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Minnesota. Samples had been collected from September 8 through October 12, 2012, from cattle, goats, sheep, and elk and white-tailed deer andwere submitted mainly for routine surveillance purposes from 29 Minnesota counties.
No HLV or SFTSV antibody test kits are currently available in the United States. We found that anti-SFTSV nucleoprotein (NP) antibodies cross-react with HLV NP and decided to use SFTSV NP antibody detection kits for detecting antibodies against SFTSV- or HLV-like viruses. A standard ELISA reagent kit, developed by Jiangsu Centers for Disease Control (6), was used to detect all subtype antibodies specific to the SFTSV NP, following the providers’ instructions. Both positive and negative controls were included, and the results of an assay were considered acceptable when the optical density (OD) of the positive and negative controls were ≥1.50 and ≤0.10, respectively. Samples with an OD value ≥2.1× the mean negative control were considered positive (6). Positivity/negativity ratios were calculated for all samples tested, and N represents the mean OD value of negative controls.
Antibodies were detected in serum samples from 64 (15.5%) of 414 cattle, 10 (10.9%) of 92 goats, 6 (12.5%) of 48 sheep, 35 (11.8%) of 296 white-tailed deer, and 7 (18.0%) of 39 elk (17.9%) (Table). Thirty-four of 64 positive samples had positivity/negativity ratios of 4–10, and 11 had ratios >10 (Figure 1). Specific antibody titers of these 11 samples ranged from 80 to 1,280 as determined by serial titration. The positive samples came from 24 of 29 counties tested (Figure 2).
Our data show that both domestic and captive farmed animals in Minnesota were exposed to SFTSV- or HLV-like virus, as evidenced by the presence of antibodies reactive against the NP of SFTSV at a prevalence ranging from 10% to 18%. Because SFTSV and HLV are closely related (4), the viruses detected in this region are most likely HLV or close relatives of HLV. Although NPs of SFTSV and HLV are antigenically cross-reactive, the observed detection rates may be underestimated because the reagents were developed and optimized for SFTSV NP antibodies. A more specific serologic test targeting HLV-specific antigens is under development; it is expected to more accurately assess the prevalence of HLV- or HLV-like virus among animals and humans.
Many arboviruses, including bunyaviruses, are zoonotic pathogens. A high fatality rate has been reported for sheep, goats, cattle, and wildlife infected with Rift Valley fever virus (RVFV) (7,8), and infections have also led to abortion in 100% of pregnant livestock. Whether the SFTSV- or HLV-like virus detected in this study is pathogenic to animals and can cause disease if transmitted to humans remains to be determined. Our records have shown that all animals that tested positive did not exhibit apparent clinical signs even though infected. Because most samples, including almost all seropositive ones, were sent to the Minnesota Veterinary Diagnostic Laboratory for surveillance purpose, the time of the animal’s infection with HLV-like virus is uncertain, but the animals were apparently healthy when sampled. However, we cannot exclude the fact that the animals may have shown clinical signs when infected with the virus.
Vertebrate animals are amplifying hosts for many arboviruses, which have seasonal epidemics (3). Distinct strategies are used by various arboviruses for interepidemic virus maintenance. Bunyaviruses, except for hantaviruses, are obligate vector-borne viruses, and their vectors include mosquitoes, ticks, and sandflies. La Crosse virus of the genus Orthobunyavirus is transmitted by mosquitoes, and rodents and foxes can be infected as amplifying hosts during seasonal outbreaks (9). RVFV is transmitted by mosquitoes as well and can infect a variety of livestock including cattle, goats, and sheep, in which the virus is amplified and transmitted to humans who are in close contact with viremic animals (10). Although a bite from an infected mosquito is critical for human infection, humans are more likely to become infected with RVFV through direct contact with viremic animals especially during the process of animal birth or abortion (11). RVFV is also confirmed to be highly infectious in aerosols (12).
SFTS epidemics in China are seasonal and occur from late March through early November. Infection rates among humans and animals rise in early March, peak in August, and decrease after November (1,2). The coincidental pattern of human epidemics and animal infections indicates that infected livestock play a critical role as amplifying hosts in SFTS epidemics. In Minnesota, the SFTSV- or HLV-like virus infects a variety of ungulates, both domesticated and wild. We also show that deer and elk (cervids) may be susceptible to this virus in this region. Farmers, hunters, and persons with outdoor lifestyles may become infected when they are bitten by infected ticks. In addition, direct contact with secretions, body liquids, or feces from viremic animals would also put these persons and veterinarians at risk, if HLV- infected animals have substantial amounts of virus in blood and other tissues. The direct contact transmission of SFTSV has been reported in family clusters among persons with no history of tick bites, suggesting that person-to-person transmission may also occur (13–15).
Evidence that a novel phlebovirus infects domesticated and captive farmed animals as shown in this study validates the concern that an SFTSV- or HLV-like emerging pathogen could pose a serious public health threat in the United States. Epidemiologic studies with a broader scope need to be conducted to elucidate viral ecology, and effective measures must be adopted to control this virus before it spreads among humans.
Dr Xing is a faculty member in the Department of Veterinary Biomedical Sciences, University of Minnesota at Twin Cities. His research interests focus on influenza viruses and bunyaviruses.
We thank Sandy Shanks for her expertise in editing the manuscript.
The work was also supported by a Minnesota Rapid Agricultural Response Fund and Grant-in-Aid grant from the Vice President’s Office of the University of Minnesota (to Z.X.). Z.X. was also supported by the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University (KFGW-200902 grant).
- Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364:1523–32.
- Kang K, Tang XY, Xu BL, You AG, Huang XY, Du YH, Analysis of the epidemic characteristics of fever and thrombocytopenia syndrome in Henan Province, 2007–2011 [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46:106–9.
- Schmaljohn CS, Nichol ST. Bunyaviridae. In: Kipe DM, Howley PM, editors. Fields virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2006.
- McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367:834–41 and.
- Niu G, Li J, Liang MF, Jiang XL, Jiang M, Yin H, Infection of domesticated animals with severe fever with thrombocytopenia syndrome virus in endemic areas of China. Emerg Infect Dis. 2013;19:756–62.
- Jiao Y, Zeng X, Guo X, Qi X, Zhang X, Shi Z, Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50:372–7.
- Ikegami T, Makino S. The pathogenesis of Rift Valley fever. Viruses. 2011;3:493–519.
- Yedloutschnig RJ, Dardiri AH, Mebus CA, Walker JS. Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus. Vet Rec. 1981;109:383–4.
- Yuill TM. The role of mammals in the maintenance and dissemination of La Crosse virus. Prog Clin Biol Res. 1983;123:77–87 .
- Wilson ML. Rift Valley fever virus ecology and the epidemiology of disease emergence. Ann N Y Acad Sci. 1994;740:169–80.
- Wilson ML, Chapman LE, Hall DB, Dykstra EA, Ba K, Zeller HG, Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. Am J Trop Med Hyg. 1994;50:663–75 .
- Smithburn KC, Mahaffy AF, Haddow AJ, Kitchen SF, Smith JF. Rift Valley fever: accidental infections among laboratory workers. J Immunol. 1949;62:213–27 .
- Liu Y, Li Q, Hu W, Wu J, Wang Y, Mei L, Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis. 2012;12:156–60.
- Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK, A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis. 2011;53:1208–14.
- Gai Z, Liang M, Zhang Y, Zhang S, Jin C, Wang SW, Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis. 2012;54:249–52.
Suggested citation for this article: Xing A, Schefers J, Schwabenlander M, Jiao Y, Liang M, Qi X, et al. Novel bunyavirus in domestic and captive farmed animals, Minnesota, USA. Emerg Infect Dis [Internet]. 2013 Sep [date cited]. http://dx.doi.org/10.3201/eid1909.130165
- Page created: December 05, 2013
- Page last updated: December 05, 2013
- Page last reviewed: December 05, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)